CRM197 recombinant protein from a Chinese bio-technology company open to partnership through distribution or commercial agency agreements.

The Chinese company, founded in 2017, offers high-quality recombinant protein for research use. Up until now, one of its core products is CRM197 (cross-reactive material 197) recombinant protein. The company is seeking partnership with potential foreign partners, and those from Europe in particular. The desired ways of cooperation include the signing of a distribution or commercial agency agreements.
The innovative Chinese company focused on bio-technology was established in 2017. It offers high-quality recombinant protein for research use. By far, CRM197 (cross-reactive material 197) recombinant protein makes one of its core products. The company’s products enable research institutions to acquire more accurate experimental results and greatly improve the research and development success in the biomedical area. The product has been used by top vaccine manufacturers and research institutions in China. Cross-reactive material 197 (CRM197 recombinant protein) is a non-toxic mutant of diphtheria toxin containing a single amino acid substitution of glycine 52 with glutamic acid. Being naturally non-toxic, CRM197 is an ideal carrier protein for conjugate vaccines against encapsulated bacteria and is currently being used to vaccinate children globally against Haemophilus influenzae, pneumococcus, and meningococcus. Now, the CRM197 recombinant protein products by the Chinese company are open to business partnership through the signing of a distribution or commercial agency agreement. The confirmed partners are expected to work with the Chinese company to jointly explore and sevice the local market.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought: 
The potential partner being sought is expected to have the required technical expertise and sales networks in vaccines and disease detection to be able to integrate these into the new type of CRM197 offered by the company. After signing a non-disclosure agreement, the Chinese company will send the interested party a specification of their products with all the details. The confirmed partner will be the Chinese company's distributor or agent in the assigned foreign market, promoting the Chinese company's CRM197 products through its own networks and marketing measures there.
External code: